Cargando…

Efficacy of Milrinone and Dobutamine in Cardiogenic Shock: An Updated Systematic Review and Meta-Analysis

OBJECTIVES: Inotropic support is commonly used in patients with cardiogenic shock (CS). High-quality data guiding the use of dobutamine or milrinone among this patient population is limited. We compared the efficacy and safety of these two inotropes among patients with low cardiac output states (LCO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abdel-Razek, Omar, Di Santo, Pietro, Jung, Richard G., Parlow, Simon, Motazedian, Pouya, Prosperi-Porta, Graeme, Visintini, Sarah, Marbach, Jeffrey A., Ramirez, F. Daniel, Simard, Trevor, Labinaz, Marino, Mathew, Rebecca, Hibbert, Benjamin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465094/ https://www.ncbi.nlm.nih.gov/pubmed/37649849 http://dx.doi.org/10.1097/CCE.0000000000000962

Ejemplares similares

Implications of Myocardial Infarction on Management and Outcome in Cardiogenic Shock
por: Jung, Richard G., et al.
Publicado: (2021)

Lactate Clearance as a Surrogate for Mortality in Cardiogenic Shock: Insights From the DOREMI Trial
por: Marbach, Jeffrey A., et al.
Publicado: (2022)

Inotropic support in cardiogenic shock: who leads the battle, milrinone or dobutamine?
por: Lozada Martinez, Ivan David, et al.
Publicado: (2022)

Impact of baseline beta-blocker use on inotrope response and clinical outcomes in cardiogenic shock: a subgroup analysis of the DOREMI trial
por: Di Santo, Pietro, et al.
Publicado: (2021)

Diagnostic accuracy of point-of-care ultrasound with artificial intelligence-assisted assessment of left ventricular ejection fraction
por: Motazedian, Pouya, et al.
Publicado: (2023)

Association between plasminogen activator inhibitor-1 and cardiovascular events: a systematic review and meta-analysis
por: Jung, Richard G., et al.
Publicado: (2018)

Methodological quality of COVID-19 clinical research
por: Jung, Richard G., et al.
Publicado: (2021)

Levosimendan, milrinone, and dobutamine in experimental acute pulmonary embolism
por: Lyhne, Mads D., et al.
Publicado: (2021)

Female Authorship in Preclinical Cardiovascular Research: Temporal Trends and Influence on Experimental Design
por: Labinaz, Alisha, et al.
Publicado: (2019)

Modifiable Risk Factors and Residual Risk Following Coronary Revascularization: Insights From a Regionalized Dedicated Follow-Up Clinic
por: Simard, Trevor, et al.
Publicado: (2021)

Milrinone or dobutamine in patients with heart failure: evidence from meta‐analysis
por: Szarpak, Lukasz, et al.
Publicado: (2022)

Effectiveness of milrinone for cardiogenic shock due to massive pulmonary aspiration: a case report
por: Park, Jeong Heon, et al.
Publicado: (2014)

Improved mortality and haemodynamics with milrinone in cardiogenic shock due to acute decompensated heart failure
por: Rodenas‐Alesina, Eduard, et al.
Publicado: (2023)

Dipyridamole and vascular healing following stent implantation
por: Simard, Trevor, et al.
Publicado: (2023)

Performance of Plasma Adenosine as a Biomarker for Predicting Cardiovascular Risk
por: Simard, Trevor, et al.
Publicado: (2020)

Progenitor Cells for Arterial Repair: Incremental Advancements towards Therapeutic Reality
por: Simard, Trevor, et al.
Publicado: (2017)

Association Between Self‐Reported Potentially Modifiable Cardiac Risk Factors and Perceived Need to Improve Physical Health: A Population‐Based Study
por: Ramirez, F. Daniel, et al.
Publicado: (2017)

Intraoperative milrinone versus dobutamine in cardiac surgery patients: a retrospective cohort study on mortality
por: Nielsen, Dorthe Viemose, et al.
Publicado: (2018)

Milrinone role in treatment of septic shock
por: Tomicic, V, et al.
Publicado: (2015)

The balloon impasse sign in percutaneous transvenous mitral valvuloplasty
por: Simard, Trevor, et al.
Publicado: (2020)

Safety of same-day discharge in patients with left main percutaneous intervention
por: Abdel-Razek, Omar, et al.
Publicado: (2022)

Contrast-free optical coherence tomography:Systematic evaluation of non-contrast media for intravascular assessment
por: Simard, Trevor, et al.
Publicado: (2020)

Stress Perfusion Cardiac Magnetic Resonance Imaging With a 3.0-Tesla Scanner for Myocardial Viability in a Patient With a Conditional Pacemaker
por: Motazedian, Pouya, et al.
Publicado: (2022)

Prognostic value of echocardiography-derived right ventricular dysfunction in haemodynamically stable pulmonary embolism: a systematic review and meta-analysis
por: Prosperi-Porta, Graeme, et al.
Publicado: (2022)

Multidisciplinary Code Shock Team in Cardiogenic Shock: A Canadian Centre Experience
por: Lee, Felicity, et al.
Publicado: (2020)

Evaluation of Plasma Adenosine as a Marker of Cardiovascular Risk: Analytical and Biological Considerations
por: Simard, Trevor, et al.
Publicado: (2019)

Rationale and Design of the Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion Trial (CAPITAL-RAPTOR)
por: Di Santo, Pietro, et al.
Publicado: (2023)

Impact of atrial fibrillation on the risk of major adverse cardiac events following coronary revascularisation
por: Jung, Richard G, et al.
Publicado: (2022)

An Unusual Case of Obstructive Shock
por: Parlow, Simon, et al.
Publicado: (2021)

Acute Heart Failure Exacerbation with Cardiogenic Shock and Elevated Systemic Vascular Resistance Treated with a Combination of Nicardipine and Dobutamine Therapy
por: Issac, Lydia E., et al.
Publicado: (2017)

Levosimendan versus dobutamine in septic shock
por: Alhashemi, JA, et al.
Publicado: (2009)

Journal Initiatives to Enhance Preclinical Research: Analyses of Stroke, Nature Medicine, Science Translational Medicine
por: Ramirez, F. Daniel, et al.
Publicado: (2020)

Cardiogenic shock /
Publicado: (2002)

Cardiogenic Shock
por: Vahdatpour, Cyrus, et al.
Publicado: (2019)

Milrinone: Is Bolus Bad?
por: Kulkarni, Venugopal
Publicado: (2018)

Effect of Cardiogenic Shock Hospital Volume on Mortality in Patients With Cardiogenic Shock
por: Shaefi, Shahzad, et al.
Publicado: (2015)

Effects of simultaneously infused terlipressin and dobutamine in septic shock
por: Morelli, A, et al.
Publicado: (2007)

CARDIOGENIC SHOCK WITH IMIPRAMINE
por: Chaudhury, S., et al.
Publicado: (1990)

Hypothermia in cardiogenic shock
por: van der Pals, Jesper
Publicado: (2012)

Phenotyping Cardiogenic Shock
por: Zweck, Elric, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1ebkjdneo3ibhl7kd8kp19pdva